Purdue Pharma

Purdue Pharma offers plan to end Sackler control and mounting lawsuits

McKinsey’s top executive voted out as consulting firm faces reckoning over opioid crisis

At the root of the opioid crisis is our belief that Big Pharma can cure pain. Can we kick that habit?

Sacklers cited fear of OxyContin lawsuits before transferring US$10-billion from Purdue Pharma, documents show

Canada’s provinces have filed opioid-related claims totalling $67.4-billion in U.S. court

McKesson says cost of opioid settlements could reach $21-billion

New York University to strip Sackler name from its Langone Medical Center following Purdue Pharma deal

OxyContin maker Purdue Pharma to plead guilty to three criminal charges as part of settlement

U.S. pursues nearly $13-billion of claims in Purdue Pharma opioid probes, sources say

U.S. pursues nearly $13-billion of penalties in Purdue Pharma opioid probes

Jonathan Sackler, co-owner of OxyContin-maker Purdue Pharma, dies at 65

Owners of OxyContin maker Purdue Pharma were paid more after company’s big fine for misleading marketing

Morning Update: Elections Alberta changes course; Pressure grows on Malta PM; Lobsters and the trade war

Purdue Pharma asks court to halt all litigation against it in Canada amid U.S. lawsuits

Purdue Pharma, facing over 2000 opioid crisis lawsuits, files for bankruptcy protection

More provinces join in class-action suit against opioid makers

More states sue opioid maker alleging deceptive marketing

B.C. alleges 20 years of deception in opioid lawsuit

B.C. to sue opioid makers for health-care expenses of overdose crisis